Thus, they may be happier self-administering medication compared with IBD patients.[14] In the present study, the costs of 2 anti-TNF-α medications were not important for the patients with UC with the regard to the choice of IFX and ADA. This evidence concerns the gene TNF and inflammatory bowel disease.